New book reveals former CEO almost moved Novo Nordisk to Switzerland
The Novo Nordisk Foundation ended up blocking a potential merger with a Swiss pharmaceutical company that would see the Danish drugmaker move headquarters.
by rasmus lange, translated by daniel pedersen
During a ten-year period lasting from 1994 to 2004, Novo Nordisk was in talks about merging with different companies, culminating in 2004 when the Danish drugmaker came close to fusing with Swiss pharmaceutical company Serono and moving headquarters from Copenhagen to Geneva, Switzerland.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novo Nordisk buys 104 acres in North Carolina
For subscribers
Novo Nordisk executive resigns
For subscribers
